Bayer CropScience Limited submitted a regulatory disclosure to BSE Limited regarding changes in promoter shareholding, as required under SEBI (Prohibition of Insider Trading) Regulations, 2015.
The filing includes two annexures containing disclosures received from the company's promoters:
Annexure 1: Disclosure from Bayer AG (Kaiser-Wilhelm-Allee 1, 51373 Leverkusen, Germany) under Regulation 7(2)(a) of SEBI PIT Regulations. The disclosure, signed by authorized signatories Alexander Burck and Dr. Jan Schell on July 9, 2026, in Leverkusen, Germany, did not contain specific transaction details in the provided data.
Annexure 2: Disclosure from Bayer CropScience AG (Alfred-Nobel-Straße 50, 40789 Monheim am Rhein, Germany) under Regulation 7(2)(a) of SEBI PIT Regulations. The disclosure, signed by authorized signatories Martin Schloemer and Markus Goblet on July 10, 2026, in Leverkusen, Germany, contained the following transaction details:
- Entity: Bayer CropScience AG (PAN: AAECB1107C, Registration No.: HRB 46985)
- Category: Promoter
- Securities Type: Equity Shares
- Holding Prior to Transaction: 53,54,030 shares (11.91% of paid-up equity share capital)
- Transaction Type: Sale
- Number of Shares Sold: 53,54,030 equity shares
- Transaction Value: ₹22,07,0,917,869.00 (₹2,207 crore)
- Date of Allotment/Acquisition: July 8, 2026
- Date of Intimation to Company: July 8, 2026
- Date of Disclosure Filing: July 10, 2026
- Mode of Transaction: Inter-se Transfer via block deal mechanism
- Exchange: NSE Limited
- Holding Post Transaction: Nil
The disclosure confirms that no derivatives trading occurred in relation to these securities. The company's compliance officer, Bharati Shetty (Membership No.: ACS 24199), submitted the filing to BSE Limited on July 10, 2026.